CSS
INFI

Cubist Systematic Strategies’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Cubist Systematic Strategies’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,691
Closed -$16K – 4771
2022
Q3 		$16K Buy
+13,691
New +$14.8K ﹤0.01% 4256
2022
Q1 		– Sell
-44,434
Closed -$100K – 3896
2021
Q4 		$100K Buy
+44,434
New +$112K ﹤0.01% 3204
2021
Q3 		– Sell
-90,500
Closed -$271K – 3252
2021
Q2 		$271K Sell
90,500
-137,750
-60% -$436K ﹤0.01% 2399
2021
Q1 		$737K Buy
+228,250
New +$761K 0.01% 1732
2019
Q2 		– Sell
-13,305
Closed -$25K – 2627
2019
Q1 		$25K Buy
+13,305
New +$19.5K ﹤0.01% 2164
2016
Q2 		– Sell
-26,772
Closed -$141K – 1930
2016
Q1 		$141K Buy
26,772
+1,599
+6% +$9.79K 0.01% 1333
2015
Q4 		$198K Sell
25,173
-6,328
-20% -$54.5K 0.01% 1356
2015
Q3 		$266K Buy
31,501
+16,171
+105% +$149K 0.01% 1304
2015
Q2 		$168K Sell
15,330
-66,020
-81% -$847K 0.01% 1502
2015
Q1 		$1.14M Buy
81,350
+28,874
+55% +$441K 0.06% 514
2014
Q4 		$886K Buy
52,476
+49,576
+1,710% +$722K 0.05% 562
2014
Q3 		$39K Buy
+2,900
New +$34.5K ﹤0.01% 1655

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Cubist Systematic Strategies's INFI Position: Q4 2022 in Review

Cubist Systematic Strategies sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 13,691 shares — an estimated $16K sold.

Cubist Systematic Strategies first reported a position in INFI in Q3 2014 and held it in 12 quarters. The position peaked at $1.14M in Q1 2015. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

  • Cubist Systematic Strategies reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 13,691 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $16K.
  • Cubist Systematic Strategies first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 12 quarters.
  • Cubist Systematic Strategies's Infinity Pharmaceuticals, Inc. position peaked at $1.14M in Q1 2015.
  • 68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.